Antidotes for direct oral anticoagulants (DOACs).

29 August 2017 (13:20 - 13:30)

Organised by:

About the speaker

Doctor Alexander Thomas Cohen

Guy's and St Thomas' NHS Trust Hospitals, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail

Welcome and introductions - New DOACs to prevent PE and stroke in HF and other hospitalized patients.

Doctor S. Goldhaber (Boston, US)

Presentation thumbnail

The critical unmet need of VTE prophylaxis in medically ill patients.

Doctor S. Goldhaber (Boston, US)

Presentation thumbnail

DOACs to prevent VTE and to reduce the risk of stroke during hospitalization and during the first several months after hospital discharge.

Mr M. Gibson

Presentation thumbnail

Case discussion - New DOACs to prevent PE and stroke in HF and other hospitalized patients.

Presentation thumbnail

Summary and concluding remarks - New DOACs to prevent PE and stroke in HF and other hospitalized patients.

Doctor S. Goldhaber (Boston, US)

Access the full session

Session thumbnail

New DOACs to prevent pulmonary embolism and stroke in heart failure and other hospitalized patients

The Event

ESC Congress 2017

29 August 2017 13:20 CET

You may be interested in

Congress Presentation

Reversal agents to improve safety in patients treated with direct oral anticoagulants (DOACs).

26 August 2022

Congress Presentation

Direct oral anticoagulants compared to warfarin in morbidly obese patients on anticoagulation: a systematic review and meta-analysis

26 April 2024

Congress Session

Arrhythmias during pregnancy: help and not harm

31 March 2025

Congress Presentation

Early DOAC therapy after invasive acute pulmonary embolism therapy: fast track PE?

20 March 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources